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The surface T cell receptor (TCR) for antigen/MHC products is composed of
adisulfide a/0 heterodimer noncovalently associated with CD3, amultipolypeptide
cell membrane complex (1, 2). In addition, a minor subset of CD3+ cells has re-
cently been shown to express C133-associated molecules different from a/0molecules,
which may represent the putative TCRy gene product (3). T cell activation can be
induced in both types of CD3+ cells by the use of lectins (i.e., PHA) or mAbs
directed against either the TCR, CD3, or CD2, another surface glycoprotein, which
is not physically linked to the CD3/TCR complex (4-6). As previously shown (7),
the interaction between surface receptors and their specific ligands elicits a series
of early metabolic events, such as an increase in free cytoplasmic Cat+ concentra-
tion ([Ca2+ ]i) and inositol-3-phosphate (InSP3)t formation. Both events are thought
to be fundamental steps in the process by which T lymphocytes are triggered to ex-
presstheir functional programs. We have recently shown that the signal transducing
mechanisms operating in CD3+ lymphocytes after stimulation via CD3 and CD2
molecules or with PHA involve activation of the classical inositol-lipid metabolism
(8, 9). An important functional consequenceof antibody-induced modulation ofthe
CD3/TCRcomplexis represented by theTcell refractoriness to anyfurtherstimulus.
This general refractoriness appears to be caused by an inhibition of the early meta-
bolic steps involved in T cell activation (10). These results provide evidence for a
regulatory role of CD3/TCR complex in the other pathways ofT cell activation and
suggest the existence of a physical association of the CD3/TCR complex with the
transducing machinery used by all other receptors coupled to PIP2 hydrolysis.
In this study we have investigated the signal-transducing mechanisms operating
in humanlymphocytesthat lack surface expression ofCD3/TCR molecules. To this
end, we derived clones from CD3- peripheral blood lymphocytes. These clones ex-
pressed the CD3-CD2+CD7+ or the CD3- CD2-CD7+ surface phenotype.
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SIGNAL TRANSDUCTION IN CD3- CELLS
We demonstrate here that a rapid increase in [Ca"]i isdetectable after anti-CD2
mAb or lectin-induced stimulation of CD3-CD2'CD7' cells. This increment in
[Ca2']i is consequent to the release of Ca" from intracellular stores and to the
influx from the extracellular compartment. In addition, PHA responses were not
affected by the antibody-induced CD2 modulation in CD3-CD2'CD7' cells.
Therefore, in CD3- lymphocytes, CD2 molecules cannot exert a regulatory role
comparable to that mediated by the CD3/TCR complex in mature T lymphocytes.
More importantly, we show that PHA can induce [Ca" ]i increase and inositol
phosphates formation also in CD3-CD2-CD7+ lymphocytes, thus indicating that
in these cells surface structures other than CD3/TCR or CD2 represent the func-
tional ligand for PHA.
Materials and Methods
MonoclonalAntibodies.
￿
mAbswithspecificity forthe CD3, CD7, and CD28moleculeswere
derivedas previously described (11). Anti-CD2 mAbs (CD2.1 andCD2.9), which in combi-
nation induce in lymphocyte clones an increase of [Ca2']; and InSP3 formation (9), were de-
rived as previously described (12).
Flow CytofluorometricAnalysis.
￿
The techniques used have been described in detail elsewhere
(13). Analysis of total PBMC for the distribution of CD3, CD2, and CD7 antigens was per-
formed using two-color fluorescence cytofluorometric analysis. Cells were stained with FITC-
conjugated OKT3 (IgG2a) mAb (Ortho Pharmaceuticals, Raritan, NJ) and anti-CD7 mAb
(IgGI) (a generous gift of Dr. B. Haynes) followed by phycoerythrin (PE)-conjugated goat
anti-mouse IgG1 (Southern Biotechnology Associates, Inc. Birmingham, AL). In other ex-
periments we used PE-conjugated OKT3 (IgG2a) mAb followed by FITC-conjugated anti-
Leu-5b (IgG2a) mAb (Becton Dickinson Immunocytometry Systems, Mountain View, CA),
or FITC-conjugated anti-Leu-5b (IgG2a) mAb and anti-CD7 (IgGl) mAb followed by PE-
conjugated goat anti-mouse IgG1. For clonal analysis, 2 x 105 clone cells were stained with
the appropriate mAb followed by fluoresceinated goat anti-mouse Ig. Control aliquots were
stained with the fluorescent reagent alone. All samples were then analyzed on a flow cytom-
eter (FAGS II; Becton Dickinson Immunocytometry Systems) gated to exclude nonviable
cells. Results are expressed as arbitrarily normalized histograms, i.e., number ofcells vs. fluores-
cence intensity.
FACS Sorting.
￿
Before sorting cells, the sample tubing ofthe FAGS were treated as previ-
ously described (14). Because the fluorescence profiles ofPBMC stained with anti-CD3 mAb
were clearly bimodal (data not shown), <5% of all cells had to be discarded because their
fluorescence intensity coincided with the inflection point of the curve. Sorted cells were col-
lected in sterile plastic tubes whose inside surfaces had been coated with sterile FCS. Once
collected, cells were immediately diluted in culture medium.
Modulation Experiments.
￿
Surface modulation ofCD2 molecules was achieved by incubating
CD3 -CD2'CD7' clones for 24 h at 37°C in the presence of saturating concentrations of
mAbs as previously described (6). To ensure the actual modulation of CD2 antigen, modu-
lated and unmodulated cloned cells were stained with appropriate anti-CD2 mAb and
fluoresceinated second reagent, and analyzed on a flow cytometer. Only when fluorescence
intensity was reduced by >90% were cloned cells further used in the studies.
Limiting Dilution Microcultures.
￿
CD3- FACS-sorted cells were seeded in limiting numbers
(from 8 to 0.5 cell/well) in round-bottomed microwels containing 105 irradiated (5,000 rad)
autologous PBMC feeder cells and 1 % (vol/vol) PHA in a final vol of0.2 ml culture medium
as previously described (14, 15). After a 24-h culture period, rIL-2 (100 U/ml) was added
to each microwell. Microcultures were then supplemented weekly with 100 R1 of rIL-2-
containing medium. After 14-21 d of culture, each microwell was assessed microscopically
for growth.
Isolation ofFresh Tumor Target Cells.
￿
Ascitic fluid was collected by paracentesis from patientsPANTALEO E r AL.
￿
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with diffuse melanoma peritoneal metastasis into sterile 500-ml bottles containing 5,000 U
heparin. The presence of neoplastic cells was confirmed by histopathological analysis. Mac-
rophages were removed by adherence to plastic flasks at 37 oC in 5% CO2 for 1 h. Tumor
cells were additionally purified by centrifugation over discontinuous Ficoll-Hypaque density
gradients as described previously (15, 16) and were frozen in several aliquots according to
standard procedures.
Assayfor CytolyticActivities.
￿
Cytolytic activity ofcell populations orlimiting dilution microcul-
tures (14, 15) was tested against the human NK-sensitive K562 and the human NK-resistant
freshly derived melanoma cells. To this end, each microculture was split into 100-w1 aliquots
and was transferred into V-bottomed wells ofmicrotiter trays with 5 x 101 "Cr-labeled target
cells in a final vol of 200 gl. Plates were centrifuged and then incubated for 4 h at 37oC.
After incubation, plates were centrifuged again and cytolysis was evaluated by counting 0.1
ml supernatant in a gamma counter. Specific lysis was evaluated as previously described (14).
Determination of Free [Ca2'J;.
￿
Determination of [Ca2' ]; was performed as previously de-
scribed (9). Briefly, CD3- CD2'CD7* and CD3- CD2 - CD7* clones (1.5 x 106/ml) were
loaded with acetoxymethyl ester of Fura-2 (1 wM final concentration) (Molecular Probes, Inc.,
Junction City, OR) and the fluorescence of the cellular suspension was monitored with an
LS-5 spectrofluorimeter (Perkin-Elmer Corp., Pomona, CA) using 2 ml quartz cuvette. The
cell suspension was excited at 340-380 nm and fluorescence was measured at 510 nm. Five-
slit widths were used for both excitation and emission. All measurements were performed
at 37oC using a thermostatically controlled cuvette holder and stirring apparatus. [Ca2- ];
were calculated by the method of Grynkiewicz et al. (17). In the Ca2' depletion experiments,
EGTA (final concentration 5 mM) was added to the cellular suspension from a 500-mM stock
(pH 7.40) 1-10 min before the addition of stimulatory mAbs (9).
Measurements of ('H]Inositol Phosphates.
￿
Measurements of inositol phosphates were per-
formed as previously described (8, 9). Briefly, incorporation of ['H]myoinositol into phos-
pholipid was achieved by incubating clone cells (2 x 106 cells/ml) in a Hepes-buffered saline
solution, supplemented with 1% glutamine and FCS (1%), with 30 RCi of [3H]myoinositol
(37 MBq/ml; Amersham Corp., Arlington Heights, IL) for 6 h at 37oC, followed by exten-
sive washing, resuspension at 2 x 106 cells/ml in the labeling solution, and incubation for
additional 60 min at 37oC. 1-ml aliquots of this cellular suspension were then transferred
to microfuge tubes and the appropriate additions were made. mAbs were added to a final
dilution of 1 :400 of ascites fluid and 17o (vol/vol) PHA. Cells were then sedimented in an
Eppendorf 5414 centrifuge. The reaction was stopped by adding chloroform/methanol (1 :2).
The phases were separated by the addition of 0.25 ml H2O and 0.25 ml chloroform, and
the upper phase was transferred to a borosilicate tube containing 5.5 ml H2O. This diluted
aqueous phase (N6 ml) was mixed with 300 pl of 100 mM disodium tetraborate (5 mM final
concentration) and stored on ice until analyzed. Extractswere subjected to ion-exchange chro-
matography using Dowex 1- x 8 anion-exchange resin (Bio-Rad Laboratories, Richmond,
CA) in formate form (1.2 ml packed resin/column). The radioactivity of the various elution
fractions was quantified by scintillation counting in Aquassure (New England Nuclear, Boston,
MA). This method does not allow to distinguish among various possible form or isomers
of InsP:, .
Results
Derivation andPhenotypic Analysis ofCD3- ClonalApulatzons
￿
PBL were separated
into CD3+ and CD3- cells using the FAGS and were cloned under limiting condi-
tions in the presence of autologous feeder cells, PHA and r-IL2 as previously de-
scribed (14) . Most CD3 + cells underwent clonal expansion, whereas -100 1o CD3-
cells were clonogenic under the culture conditions used (18). In view ofthe low numbers
of CD3' cells plated per microwell and of the relatively low cloning efficiency ob-
served in this subset, the majority of limiting dilution proliferating CD3- microcul-
tures could be operationally considered as clones. Selection of CD3- clones was also16
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FIGURE 1 .
￿
Cytofluorometric analysis ofCD7, CD2, and CD3 antigen expression in peripheral
bloodand in cloned lymphocytes . (A)PBLwere stained with FITC-anti-CD2mAbandPE-anti-
CD3mAb (a), or with FITC-anti-CD3 andPE-anti-CD7 (b), or with FITC-anti-CD2 andPE-anti-
CD7 (c) as described in Materialsand Methods . Based on control samples, the contour plot was
divided into quadrants representing unstained cells (lower left), cells with only red fluorescence
(upper left), cells with red and green fluorescence (upper right) and cells with only green fluores-
cence (lower right) . (B) 2.3 is a CD3-CD2'CD7' clone, whereas G29 is a CD3-CD2 -CD7'
clone. Cells were stained with various mAbs by indirect immunofluorescence and analyzed on
the FRCS . Background fluorescence given by cells stained with second reagent alone is shown
in each histogram .
based on their ability to proliferate sufficiently to give numbers of cells suitable for
different studies, including phenotypic and functional analysis as well as analysis
of the signal-transducing mechanisms .
We first analyzed the distribution of CD3 and CD2 antigens in resting PBL by
two-color fluorescence cytofluorometry (Fig. 1 A, panel a) . Although most CD2+
lymphocytes coexpressed CD3 antigen, a subset (9.3% in the experiment shown)
of CD2' cells did not . Similarly, when PBL were analyzed for expression ofCD7
and CD3 (Fig . 1 A, panel b), a subset ofCD7+ cells (15.6%) did not expressCD3 .
Moreover, when the same PBL population was analyzed for the expression ofCD7
and CD2 antigens (Fig . 1 A, panel c) a small fraction of cells (6 .3%) displayed the
CD7+CD2- surface phenotype .
Clones expressing a similar CD3-CD2+CD7+ and CD3-CD2-CD7+ surface
phenotype were obtained by cloning CD3- PBL. The surface phenotype of two
among the five clones selected for detailed analysis is shown in Fig. 1 B. Clone 2 .3
is representative of CD3-CD2+CD7+ clones, whereas clone G29 is representativePANTALEO ET AL.
TABLE I
Cytolytic Activity of CD3- CD2'CD7' and CD3- CD2- CD7' Clones
' Data are expressed as percent5'Cr release. The E/T ratio used in this experi-
ment was 2 :1.
t Clones 2 .3 and LG2 are CD3- CD2'CD7' . Clones 2.1, G29 and LAll are
CD3- CD2- CD7' .
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of CD3-CD2-CD7+ clones. Although not shown all the five clones examined were
also CD4- , CD8- and CD28- .
Functional Analysis of CD3- Clones.
￿
Previous studies (15) performed in our labo-
ratory have shown that CD3-CD2'CD7+ clones display a broad cytolytic activity
against a panel ofdifferent target cells, including the NK-sensitive K562 cell line,
NK-resistant cell lines, and different types offresh tumor target cells. In contrast,
the majority ofCD3-CD2+CD7+ clones didnot release significant amounts ofIL-2
upon stimulation regardless ofthe stimulusused (including anti-CD2 mAbs, PHA,
and ionomycin) (18). Table I summarizes the functional characteristics of three
CD3-CD2-CD7+ clones and two CD3-CD2*CD7+ clones. It is evident that
CD3-CD2-CD7+ clones, similar to CD3- CD2+CD7+ clones, displayed a strong
cytolytic activity against the NK-sensitive K562 cell line and were also able to lyse
NK-resistant freshly derived human melanoma cells.
Analysis ofSignal-transducing Mechanisms in CD3- CD-"' CD7' Clones.
￿
We first in-
vestigated whether stimulation via CD2 molecules or with PHA could induce an
increase in [Ca2+]; in CD3- CD2+ clones. As shown in Fig. 2, the use ofeither a
suitable combination of anti-CD2 mAbs (A and E) or of PHA (C and G) elicited
a rapid increase in [Ca2+]; in both LG2 (A and C) and 7..3 (E and G) clones. When
the experiments were performed in the absence ofextracellular Cat' a transient in-
crease in [Ca2+ ]; was still detectable after stimulation with anti-CD2 mAbs (B and
F) and PHA (D and H). These results indicate that the increase in [Ca2+]; observed
in the presence of extracellular calcium was due to release of Cat' from intracel-
lularstores and toan influx fromthe extracellularcompartment. Itshould bestressed
that the small increase in [Ca2+ ]i detected in the absence ofextracellular Cat' after
anti-CD2 mAb stimulation, has to be considered specific, since addition ofTriton
X-100 at theendofthestimulation period did not increase furtherthe levels offluores-
cence (Fig. 2).
The results on Cat+ mobilization suggested that in CD3- clones the metabolic
pathway operating in the transduction ofthe signal via CD2 molecules or PHA in-
volved the classical inositol lipid metabolism, as is the case in CD3+ cells. To sub-
stantiate this hypothesis, we determined whether stimulation ofCD3- cells by anti-
CD2 mAbs or PHA caused an increase in the level ofinositol phosphates. As shown
in Fig. 3, stimulation with PHA caused a significant increase of InSP3 (panel C)
Clonel K-562
5'Cr-labeled target cells'
Melanoma
2.3 95 47
LG2 100 ND
2 .1 87 35
G29 91 25
LAl l 100 ND18
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Increase in [Ca2+]; mediated by
anti-CD2 mAbs or PHA in CD3` CD2+
CD7' clones. (A and E) Increase in [Ca2+];
mediated by anti-CD2 mAbs in LG2 and2.3
clones, respectively. (C and G) [Ca2+]; incre-
ments after PHA stimulation in the same
clones. Thecells wereplaced in thefluorimeter
andstimulated with either astimulatory com-
bination of anti-CD2 mAbs (1 :800 of ascite
fluid) or 1% (vol/vol) PHA. (A, C, E, and G)
The different stimuli were added in thepres-
ence of 1 mM extracellular Cat'; (B, D, F,
andH) [Ca2+ ]; increases in response to anti-
CD2 mAbs (B, F) or PHA (D, H) were ex-
amined after depletion ofextracellular Cat'
by EGTA (10mM finalconcentration). EGTA
was added 2 min before addition of the
stimulus. Triton X-100wasadded at thefinal
concentration of 0.1%. Arrows indicate the
time oftheaddition ofthestimuli [Ca2+]; cal-
culated by themethod of Grynkiewicz et al.
(17) is displayed on the vertical axis.
(the mobilizer ofCat+ from intracellular stores) as well as of(InSP2) (panel B) and
InsPi (panel A). In contrast, stimulation with anti-CD2 mAbs did not induce de-
tectable increments in the various inositol phosphates (Fig. 3). Thelack ofincrease
in inositol phosphates, after anti-CD2 mAb stimulation, in our view, could be ex-
plained by the higher sensitivity of the Cat' assay as compared with the inositol
phosphate assay.
Previous studieshave suggestedthat theCD3/TCR complex and theCD2 molecules
could representthe ligand forPHA on the surface ofhumanTlymphocytes (19-21).
The results presented above clearly demonstrate that PHA can transduce a signal
in cells that lack surface expression ofCD3/TCR complex. To answer the question
whether the signaling mediated by PHA occurs via surface CD2 molecules, we in-
duced surface modulation ofCD2 molecules in 2.3 clone. As shown in Fig. 4 (right
inset, bottom) after a 24-h incubation period in the presence of saturating doses of
anti-CD2 mAbs, cells from clone 2.3 displayed a negative surface staining foranti-
CD2 mAbs. The ability of anti-CD2 mAbs and PHA to induce increments in
[Ca2+]; was then determined in unmodulated and CD2-modulated 2.3 cells. Fig.
4 shows that in the latter cells the increase in [Ca2+]; mediated by anti-CD2 mAbs
was completely abrogated (C), whereas the [Ca2+]; increase mediated by PHA was
unaffected (F).
TransmembraneSignaling in CD3-CDrCD7' Clones.
￿
We next analyzed three rep-
resentative clones thatexpressedsurface CD7 antigen but didnot expressdetectable
surface CD3 and CD2 antigens. These clones represented a useful tool in order toa
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FIGURE 3.
￿
Levels of [3H]inositol phosphates in CD3-CD2'CD7' LG2 clone stimulated with
anti-CD2 mAbs or PHA. (A) Levels of Inspl afteranti-CD2 (-A-) or PHA (--A-) stimulation.
(B) Insp2 levels after anti-CD2 (-*-) or PHA (-O-) stimulation. (C) InSP3 levels mediated
by anti-CD2 (--W-) or PHA (-¢). Theindicatedtime points arerepresentative of theintervals
from the addition of the stimulus to the lysis in chloroform/methanol(1:2). Data are expressed
as counts per minute after subtraction of background levels.
clarify whether PHA could trigger a response in the absence of CD2 molecules as
previously suggested by CD2 modulation experiments in CD3-CD2+CD7+ clones.
To this end, clones were labeled with the fluorescent Cat+ dye Fura-2 and stimu-
lated with PHA. As shown in Fig. 5, in all instances, a rapid increase in [Ca2' );
was observed after PHA stimulation either in the presence (A, C, and E) or in the
absence (B, D, and F) of extracellular Cat+ . Moreover, as shown in Fig. 6, stimu-
lation with PHA induced a significant increase in the levels of the various forms
of inositol phosphates in the two clones analyzed. Since these cells express the T
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FIGURE 4.
￿
Effect of modulation of surface CD2 molecules on the [Ca2+ ]; increments induced
by PHA in the CD3-CD2'CD7' 2.3 clone. Unmodulated2.3 cells were stimulated with anti-
CD2 mAbs (A, B) or PHA (D, E) in the presence or absence of extracellular Ca2'. (C) CD2-
modulated 2.3 cellsstimulated with anti-CD2 mAbs. (F) Increase in [Ca2' ]i after PHA stimu-
lation in C132-modulated 2.3 cells. Arrows indicate thetime of addition ofthestimuli. Theinset
(right) shows CD2 expression in unmodulated (top) and in C132-modulated (bottom) 2.3 cells.
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Analysis of [Ca2+1; in-
crease in CD3- CD2- CD7+ clones
in response to PHA. (A, G, and E)
[Ca2` ]; increments mediated by
PHA in LAII, G29, and 2.1 clones,
respectively. The stimulus was add-
ed in presence of 1 mM exttacel-
lular Ca2+ . (B, D, andF) Increase
in [Ca211i after depletion of ex-
tracellular Ca2+ by EGTA. Arrows
indicate the time ofthe addition of
the stimuli.
cell lineage-related CD7 antigen, we analyzed whether the use of anti-CD7 mAbs
(either alone or in combination) would result in signal transduction similar to that
observed by using PHA. In no instances could (Ca2+ ]; increases in the presence of
anti-CD7 antibodies be observed.
Discussion
In this study, we analyzed the signal-transducing mechanisms operating in cyto-
lytic clones that lack surfaceexpression of the CD3/TCRcomplex(C]33-a/p or CD3-
y-S). Two major phenotypically distinct clonal populations could be derived from
CD3- sorted lymphocytes. The first is characterized by the surface expression of
CD2 and CD7 antigens, while the second expresses surface CD7 but not CD2 an-
tigens. Both CD3-CD2*CD7' and CD3-CD2-CD7' cells did not express surface
CD4, CD8, or CD28 antigen. Functional analysis demonstrated that both types of
cellshad a strong cytolyticactivity against NK-sensitive as well as NK-resistant tumor
target cells (15). In addition, both types of cytolytic clones were usually unable to
produce IL-2, whereas they released significant amounts of IFN-Y after cell stimu-
lation with calcium ionophore A23187 and PMA (18).
Previous studies, designed to clarify the functional interactions among the var-
ious pathways involved in Tcell activation (i.e., CD3/TCR complex, CD2 molecules,
activation via PHA), have clearly demonstrated that the CD3/TCR complex exerts
a regulatory control on the other pathways of T cell activation (5, 6). In addition,
we showed that the general T cell refractoriness that follows antibody-induced sur-
face modulation of the CD3/TCR complex can be explained by the inhibition of
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Figure 6. PHA stimulation
induces increased levels of
[ 3H]inositol phosphates in
CD3-CD2-CD7' clones. (A,
B, and C) Levels of [3H]InsPl
(A), [3H] InSP2 (O), and
["H]InSP3 (0) in G29 clone in
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the early metabolic steps involved in T cell activation, such as the increase in [Ca2+]i
and the formation of inositol phosphates (10). An alternative approach has been to
analyze CD3-TCR-CD2+ cell variants, derived from the IL-2-producing leukemia
T cell line Jurkat. By using this approach, Weiss et al. (22) demonstrated that the
loss of surface expression of the CD3/TCR complex ledto functional unresponsive-
ness of the variant to PHA and to a metabolic block that is evidenced by the lack
of [Ca2+ ]; increase after stimulation with PHA. However, a group of similar
CD2+TCR-CD3-variants, obtained from the same cell line in our laboratory, was
found to be responsive to anti-CD2 mAbs and at least in one case to PHA (23).
Therefore, these data already suggestedthat the loss of the CD3/TCR complex does
not necessarily lead to the loss of cell responsiveness and that at least in some
CD3-/TCR- variants the transducingmachinery may be conserved and functional.
On the other hand, in these artificially obtained CD3- cells different mutational
events may be responsible forthedifferent functional behavior ofdistinct T cell var-
iants. Thus, we analyzed cells that constitutively lack surface CD3 molecules.
The analysis ofclones derived from normal PBL provided the opportunity to in-
vestigate whetherthe transmembrane signaling via CD2 molecules or mediated by
PHA can still be observed in cells that constitutively lack the surface CD3/TCR
complex. On the basis of the proposed strict link between the CD3/TCR complex
and the transducing machinery in the membrane, one may expect that the trans-
membrane signaling mediated by CD2 molecules or PHA could be abrogated in
cells lacking CD3/TCR structures. In this regard, Alcover et al. (24) showed that
an increase in [Ca2+]; could be detected in CD3-CD2+ cells. This increment was
only dependent upon an influx from the extracellular compartment. However, the
stimulatory combinationof anti-CD2 mAbs used in the above studydifferently from
our anti-CD2 mAbs failed to mobilize Ca2+ from intracellular stores also in CD3+
cells (25). Our results clearly demonstrate that in CD3-CD2+CD7+ cells the signal-
transducing mechanisms after receptor-ligand interaction are conserved and that
an activation of the classical inositol lipid metabolism is involved. In addition, our
data suggestthat the regulatory function oftheCD3/TCR complexon otherpathways22
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ofT cell activation occurs only in cells that bear TCR structures. Therefore, in cells
that constitutively do not express the CD3/TCR complex the lack of these structures
does not prevent the cell responsiveness via other pathways of activation.
The analysis of signal-transducing mechanisms in the CD3- CD2 + CD7 + clones
also allowed us to investigate whether, in the absence of surface CD3 expression,
the regulation oflymphocyte responses could be assigned to CD2 molecules. Moreover,
we could evaluate the involvement of CD2 molecules in the stimulation mediated
by PHA. We showed that mAb-induced surface modulation ofCD2 molecules com-
pletely abrogated the increase in [Ca2+ ]i after stimulation with anti-CD2 mAb,
whereas it did not affect the [Ca2+ ]; increase mediated by PHA. These results indi-
cate that CD2 molecules do not substitute for the CD3/TCR complex in regulating
other pathways of activation in CD3 - TCR- cells and that PHA stimulation is in-
dependent of the surface expression of CD2 molecules.
The analysis of transmembrane signaling in CD3 - CD2 - CD7* clones demon-
strated that the PHA induced activation ofthis type ofcells does not require surface
expression of CD3/TCR or CD2 molecules. Thus, although previous studies per-
formed in CD3+ cells suggested that the CD3/TCR complex and CD2 molecules
may represent the ligand for PHA (19-21), our present results indicate that the lectin-
induced cell triggering may occur via othersurface molecules than CD3/TCR or CD2 .
Whether these other surface PHA-binding molecules present in CD3 - TCR - cells
are also expressed in CD3'TCR' lymphocytes has still to be determined. Thus,
the downregulation of the PHA-dependent T cell activation, which follows surface
modulation ofthe CD3/TCR complex, may not simply be due to the lack ofexpres-
sion of the proposed ligand (CD3/TCR complex) for PHA. On the contrary, dis-
tinct PHA-binding molecules similar to those present in CD3' cells may still be
expressed after CD3/TCR modulation. If this is the case, the inhibitory effect of
the antibody-induced modulation of the CD3/TCR complex on the PHA-induced
cell activation is likely to be consequent to the downregulation of the transducing
machinery in the membrane rather than to the loss of the cell surface ligand for
PHA. One may speculate that in view of the ability to transduce activation signals
provided by PHA, this molecule may represent a still undefined surface receptor
involved in the MHC-nonrestricted cytolytic activity commonly observed in CD3-
clones.
Summary
We have analyzed the transmembrane signaling operating in human cytolytic lym-
phocytes lacking surface expression ofthe CD3/TCR complex. Peripheralblood lym-
phocytes were fractionated into CD3 + and CD3 - on the FACS and cloned under
limiting conditions in the presence of PHA and IL-2. Approximately 907o CD3+
and 10% CD3 - cells underwent clonal expansion. Clones obtained from the CD3-
fraction belonged to two main phenotypic groups: CD2 + CD7+ and CD2- CD7+ .
Several clones were expanded and analyzed for surface phenotype and function. All
ofthe five clones selected for detailed analysis did not express CD4, CD8, and CD28
antigens and did not release IL-2, whereas they displayed cytolytic activity against
NK-sensitive, NK-resistant, and fresh tumor target cells.
After stimulation with anti-CD2 mAbs or PHA a rapid increase in [Ca2+]; was
detected in CD3- CD2+CD7 + clones. This increment was caused by the release ofCa" from intracellular stores and by the influx from the extracellular compartment.
Signaling in response to PHA did not appear to be dependent upon surface expres-
sion of CD2 molecules since antibody induced modulation of CD2 did not prevent
PHA-induced signal transduction.
Similarly, in CD3'CD2- CD7 + clones [Ca2+ ]i increments and inositol phosphate
formation occurred after stimulation with PHA.
These data indicate that the functionalPHA-binding structures, expressed in both
groups of CD3 - clones, are distinct from CD3/TCR complex and CD2 molecules.
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